Operil P Za Djecu (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride, the active ingredient in Operil P Za Djecu, is an Alpha‑2‑adrenergic receptor agonist presented as a nasal spray for topical use. It relieves nasal congestion in children by constricting blood vessels in the nasal mucosa. GNH USA supplies Operil P Za Djecu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Operil P Za Djecu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Operil P Za Djecu contains oxymetazoline, a topical nasal decongestant that acts on the nasal mucosa to reduce swelling and improve airflow.

- Acute nasal congestion: Provides rapid relief of nasal blockage due to colds or allergies. - Seasonal allergic rhinitis: Helps alleviate congestion associated with hay fever in children. - Mild sinusitis: Assists in reducing nasal obstruction during early stages of sinus inflammation.

Oxymetazoline nasal spray may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Burning sensation - Stinging or irritation - Nasal dryness - Sneezing - Mild headache - Transient nasal bleeding

Serious or Rare Side Effects: - Persistent nasal congestion (rebound congestion) - Severe hypertension - Cardiac arrhythmia - Allergic reaction with rash or swelling - Nasal ulceration - Vision changes

When using Operil P Za Djecu, consider the following safety measures:

- Age restriction: Not recommended for children under 6 years without medical advice. - Duration of use: Limit to no longer than 3‑5 days to avoid rebound congestion. - Pre‑existing conditions: Use cautiously in patients with hypertension, heart disease, diabetes. - Concomitant nasal medications: Avoid using other topical decongestants simultaneously. - Pregnancy and lactation: Consult a healthcare professional before use. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Oxymetazoline may interact with certain systemic medications and other nasal products.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): May potentiate hypertensive effects. - Sympathomimetic agents: Combined use can increase blood pressure.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: May reduce efficacy of blood pressure control. - Nasal corticosteroids: Monitor for increased local irritation. - Antihistamines: May enhance drying of nasal mucosa. - Decongestant tablets oral: Combined systemic decongestant effect may raise blood pressure. - Alcohol: May increase risk of dizziness.